135 related articles for article (PubMed ID: 17045206)
1. p53 family members in myogenic differentiation and rhabdomyosarcoma development.
Cam H; Griesmann H; Beitzinger M; Hofmann L; Beinoraviciute-Kellner R; Sauer M; Hüttinger-Kirchhof N; Oswald C; Friedl P; Gattenlöhner S; Burek C; Rosenwald A; Stiewe T
Cancer Cell; 2006 Oct; 10(4):281-93. PubMed ID: 17045206
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays.
Carey KA; Segal D; Klein R; Sanigorski A; Walder K; Collier GR; Cameron-Smith D
Pathol Int; 2006 May; 56(5):246-55. PubMed ID: 16669873
[TBL] [Abstract][Full Text] [Related]
3. The role of p53 in vivo during skeletal muscle post-natal development and regeneration: studies in p53 knockout mice.
White JD; Rachel C; Vermeulen R; Davies M; Grounds MD
Int J Dev Biol; 2002; 46(4):577-82. PubMed ID: 12141446
[TBL] [Abstract][Full Text] [Related]
4. Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.
Nanni P; Nicoletti G; De Giovanni C; Croci S; Astolfi A; Landuzzi L; Di Carlo E; Iezzi M; Musiani P; Lollini PL
Cancer Res; 2003 Jun; 63(11):2728-32. PubMed ID: 12782574
[TBL] [Abstract][Full Text] [Related]
5. Identification of flotillin-2, a major protein on lipid rafts, as a novel target of p53 family members.
Sasaki Y; Oshima Y; Koyama R; Maruyama R; Akashi H; Mita H; Toyota M; Shinomura Y; Imai K; Tokino T
Mol Cancer Res; 2008 Mar; 6(3):395-406. PubMed ID: 18296650
[TBL] [Abstract][Full Text] [Related]
6. Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells.
Yan W; Chen X
Cancer Res; 2007 Oct; 67(19):9117-24. PubMed ID: 17909016
[TBL] [Abstract][Full Text] [Related]
7. [Rhabdomyosarcoma development in Trp53/fos mutant mice: tumor suppressor functions of the Fos protooncogene].
Jochum W
Verh Dtsch Ges Pathol; 2004; 88():224-30. PubMed ID: 16892556
[TBL] [Abstract][Full Text] [Related]
8. RB, the conductor that orchestrates life, death and differentiation.
Khidr L; Chen PL
Oncogene; 2006 Aug; 25(38):5210-9. PubMed ID: 16936739
[TBL] [Abstract][Full Text] [Related]
9. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
[TBL] [Abstract][Full Text] [Related]
10. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation.
Figliola R; Busanello A; Vaccarello G; Maione R
J Mol Biol; 2008 Jul; 380(2):265-77. PubMed ID: 18513743
[TBL] [Abstract][Full Text] [Related]
11. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
12. Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice.
Tsumura H; Yoshida T; Saito H; Imanaka-Yoshida K; Suzuki N
Oncogene; 2006 Dec; 25(59):7673-9. PubMed ID: 16785989
[TBL] [Abstract][Full Text] [Related]
13. p63 in Mytilus galloprovincialis and p53 family members in the phylum Mollusca.
Stifanić M; Micić M; Ramsak A; Blasković S; Ruso A; Zahn RK; Batel R
Comp Biochem Physiol B Biochem Mol Biol; 2009 Nov; 154(3):264-73. PubMed ID: 19563905
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors.
Martínez-Cruz AB; Santos M; Lara MF; Segrelles C; Ruiz S; Moral M; Lorz C; García-Escudero R; Paramio JM
Cancer Res; 2008 Feb; 68(3):683-92. PubMed ID: 18245467
[TBL] [Abstract][Full Text] [Related]
15. p53-mediated activation of miRNA34 candidate tumor-suppressor genes.
Bommer GT; Gerin I; Feng Y; Kaczorowski AJ; Kuick R; Love RE; Zhai Y; Giordano TJ; Qin ZS; Moore BB; MacDougald OA; Cho KR; Fearon ER
Curr Biol; 2007 Aug; 17(15):1298-307. PubMed ID: 17656095
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 gain of oncogenic function: in vivo evidence, mechanism of action and its clinical implications.
Adhikari AS; Iwakuma T
Fukuoka Igaku Zasshi; 2009 Jun; 100(6):217-28. PubMed ID: 19670804
[TBL] [Abstract][Full Text] [Related]
17. Myogenesis and rhabdomyosarcoma the Jekyll and Hyde of skeletal muscle.
Saab R; Spunt SL; Skapek SX
Curr Top Dev Biol; 2011; 94():197-234. PubMed ID: 21295688
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: an immunohistochemical and immunoelectron microscopic study.
Martin SE; Temm CJ; Goheen MP; Ulbright TM; Hattab EM
Mod Pathol; 2011 Oct; 24(10):1320-6. PubMed ID: 21623385
[TBL] [Abstract][Full Text] [Related]
19. The Rb family connects with the Tp53 family in skin carcinogenesis.
Lara MF; Paramio JM
Mol Carcinog; 2007 Aug; 46(8):618-23. PubMed ID: 17486638
[TBL] [Abstract][Full Text] [Related]
20. Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.
Puca R; Nardinocchi L; Gal H; Rechavi G; Amariglio N; Domany E; Notterman DA; Scarsella M; Leonetti C; Sacchi A; Blandino G; Givol D; D'Orazi G
Cancer Res; 2008 May; 68(10):3707-14. PubMed ID: 18483253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]